| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $161K | — | -98.8% |
| SG&A Expense | $4.7M | — | +54.9% |
| Operating Income | -$4.8M | — | +69.7% |
| Pre-tax Income | -$82.3M | — | -433.1% |
| Income Tax | -$5.1M | — | — |
| Net Income | -$77.2M | — | -399.9% |
| EPS (Basic) | -$0.46 | — | -24.3% |
| EPS (Diluted) | -$0.46 | — | -24.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.7M | -52.3% | -79.6% |
| Current Assets | $81.9M | -49.5% | +141.9% |
| Total Assets | $87.4M | -46.5% | +150.5% |
| Current Liabilities | $3.0M | -34.1% | -78.6% |
| Total Liabilities | $3.0M | -69.0% | — |
| Stockholders' Equity | $84.4M | -45.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | +76.3% |
| Investing Cash Flow | -$9.0M | — | — |
| Financing Cash Flow | $5.1M | — | +8419.7% |
| +304.9% |